Brief: Giant Biogene Holding Posts H1 Net Income RMB 980.6 million
19/08/2024 12:33
Aug 19 (Reuters) - Giant Biogene Holding H1 capex RMB 164.7 million. * H1 gross margin 82.4% * H1 basic EPS RMB 0.99 * H1 gross profit RMB 2,093.2 million * H1 EPS RMB 0.97 * H1 net income RMB 980.6 million
Recent news on Giant Biogene Holding
See all newsGiant Biogene's profit drops on higher distribution expenses
Brief: Giant Biogene Says Cross-Linked Recombinant Collagen Implant Receives China Medical Device Registration Certificate
Brief: Giant Biogene To Distribute Final Dividends Of Rmb0.5390 Per Share
Brief: Giant Biogene's Unit Received NMPA Medical Device Registration Certificate For Recombinant Collagen, Sodium Hyaluronate Solution
HK-listed Giant Biogene jumps on share buyback plan